Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Verweij

Showing results (1-10 of 655) with videos related to

Pageof 66
Sort By:
European Journal of Cancer (Oxford, England : 1990)|December 9, 1997
Etoposide for soft tissue sarcomas: fact or fictionJ Verweij
Cancer Chemotherapy and Biological Response Modifiers|November 1, 2001
SarcomasJ Verweij
Oncology|August 7, 1999
Rational design of new tumoractivated cytotoxic agentsJ Verweij
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 1998
High-dose ifosfamide for soft tissue sarcomas: set the scene, or senescence?J Verweij
British Journal of Cancer|August 1, 1994
Docetaxel (Taxotere): a new anti-cancer drug with promising potential?J Verweij
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1996
The benefit of clinical benefit: a European perspectiveJ Verweij
Anti-Cancer Drugs|July 1, 1995
Docetaxel: an interesting new drug for the treatment of head and neck cancers and soft tissue sarcomasJ Verweij
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Topoisomerase I inhibitors and other new cytotoxic drugsJ Verweij
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1997
MitomycinsJ Verweij
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1996
MitomycinsJ Verweij
Pageof 66

Showing results (1-10 of 655) with videos related to

Sort By:
Pageof 66
European Journal of Cancer (Oxford, England : 1990)|December 9, 1997
Etoposide for soft tissue sarcomas: fact or fictionJ Verweij
Cancer Chemotherapy and Biological Response Modifiers|November 1, 2001
SarcomasJ Verweij
Oncology|August 7, 1999
Rational design of new tumoractivated cytotoxic agentsJ Verweij
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 1998
High-dose ifosfamide for soft tissue sarcomas: set the scene, or senescence?J Verweij
British Journal of Cancer|August 1, 1994
Docetaxel (Taxotere): a new anti-cancer drug with promising potential?J Verweij
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1996
The benefit of clinical benefit: a European perspectiveJ Verweij
Anti-Cancer Drugs|July 1, 1995
Docetaxel: an interesting new drug for the treatment of head and neck cancers and soft tissue sarcomasJ Verweij
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Topoisomerase I inhibitors and other new cytotoxic drugsJ Verweij
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1997
MitomycinsJ Verweij
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1996
MitomycinsJ Verweij
Pageof 66